This is the most common form of Multiple Sclerosis. People with this type experience periods where their symptoms get worse (relapses or attacks), followed by periods where they get better (remissions). The symptoms can vary widely and might include vision problems, muscle weakness, numbness, or trouble walking. The disease can come and go over many years.
Every report comes from a Lived member, sent anonymously.
Have you tried Ocrevus (Ocrelizumab) for Relapsing-Remitting Multiple Sclerosis?
Relapsing-remitting multiple sclerosis (RRMS) is the most common form of multiple sclerosis (MS), a long-term disease of the brain and spinal cord. In MS, the immune system attacks myelin, the protective coating around nerve fibers, which slows or blocks signals between the brain and the rest of the body. Most people with MS are first diagnosed with this form. The name describes its pattern. Relapses (also called attacks or flare-ups) bring new symptoms or a clear worsening of old ones, followed by partial or full recovery. The calmer stretches in between are called remissions, and weeks, months or even years can pass before the next relapse. What a relapse feels like depends on where the inflammation is: blurred vision or pain when moving one eye, numbness or tingling, weakness in an arm or leg, poor balance, dizziness or bladder problems are common examples. Fatigue, mood changes and difficulty concentrating can be present even between relapses.
No one knows exactly why MS develops. It appears to arise from a combination of genetic susceptibility and environmental exposures rather than a single cause. MS usually begins between ages 20 and 40 and is two to three times more common in women than in men. Having a parent or sibling with MS raises the chance, although MS is not directly inherited; many genes each contribute a small share of the risk. Earlier infection with Epstein-Barr virus, the cause of mononucleosis, is the infection most consistently linked to MS, but almost everyone has had it and only a very small fraction develop MS. Smoking, little sun exposure and low vitamin D levels are associated with higher risk, and people who smoke tend to have a more aggressive course. Once someone has MS, relapses often arrive without an obvious trigger. Separately, heat, fever, infection or stress can temporarily bring back old symptoms. This is called a pseudorelapse: it is not a new attack, and it fades once the trigger passes.
No single test confirms MS. A neurologist pieces together the history of symptoms, a neurological exam (checking vision, strength, sensation, reflexes and coordination) and test results. The aim is to show that inflammation has affected different parts of the nervous system at different times, and to rule out conditions that can look similar. MRI (magnetic resonance imaging) of the brain and spinal cord is the key test. It shows lesions, the small scarred patches MS leaves behind, including ones that never caused symptoms. A contrast dye given through a vein highlights lesions that are currently inflamed, which helps show the disease has been active at more than one point in time. A lumbar puncture (spinal tap) may check the spinal fluid for oligoclonal bands, antibody patterns that point to inflammation inside the central nervous system. Blood tests help exclude look-alike conditions, and eye tests such as optical coherence tomography (OCT), a quick scan of the back of the eye, or visual evoked potentials, which measure how fast signals travel from the eye to the brain, can detect damage to the optic nerve. These findings are weighed using the McDonald criteria, an international standard updated in 2024 to allow earlier diagnosis in some people with very characteristic results. RRMS specifically describes a pattern of distinct relapses with recovery between them. A single first episode may be called clinically isolated syndrome, although MRI or spinal fluid findings can sometimes confirm MS after just one attack.
There is no cure for MS, but treatment can reduce relapses and slow the disease. Care has three parts: long-term medicine to prevent relapses, short-term treatment when a relapse happens, and help with day-to-day symptoms. Disease-modifying therapies (DMTs) are the long-term medicines. They calm or redirect the immune attack, which reduces how often relapses happen and how many new lesions appear on MRI, and they can delay the gradual worsening some people later develop. In trials, they cut the yearly relapse rate by roughly 30% to nearly 70%, depending on the medicine. They do not repair damage already done, which is one reason treatment decisions are usually made soon after diagnosis. DMTs come as self-injections, pills and infusions given in a clinic. Broadly, the most powerful options, such as ocrelizumab (Ocrevus) and natalizumab (Tysabri), mostly given by infusion, prevent more relapses but suppress the immune system more, while older injectable medicines and some pills, such as dimethyl fumarate (Tecfidera), are milder and carry different side effects. Choosing among them balances how active the MS is, infection risk and other side effects, how the medicine is taken, the monitoring it needs and any pregnancy plans. Most require regular blood tests. Natalizumab, for example, carries a risk of PML (progressive multifocal leukoencephalopathy), a rare but serious brain infection, so people taking it have blood tests for antibodies to the virus that causes it. A relapse that affects daily function, such as vision loss or weakness, is often treated with a short course of high-dose corticosteroids, usually methylprednisolone for 3 to 5 days, given by vein or in an equivalent high oral dose. Steroids speed recovery but do not change the long-term course, so a mild relapse, such as numbness that does not limit activity, may simply be watched. Plasma exchange, which filters antibodies out of the blood, is reserved for severe relapses that do not respond to steroids. For everyday symptoms, physical and occupational therapy help with strength, balance, walking and fatigue, and specific medicines can ease muscle stiffness, bladder problems, nerve pain and depression. Dalfampridine (Ampyra) is a pill approved to improve walking speed in people whose MS affects their walking. Staying physically active matters, because inactivity can worsen stiffness, weakness and fatigue.
RRMS is lifelong, and its course varies widely. Some people have mild symptoms and little disability for many years; others build up lasting problems faster. Treatment can make relapses less frequent or stop them for long periods, and most people with MS have a normal or near-normal life expectancy. Recovery after a relapse may be complete, or some symptoms may linger. Over time, many people with RRMS move into secondary-progressive MS, in which disability increases gradually with fewer or no relapses. DMTs can delay and sometimes prevent this shift, but it can still happen during treatment. Between relapses, the less visible symptoms often shape daily life the most. Fatigue is common, as are problems with concentration or memory, mood changes and depression, and bladder or bowel issues. Because heat and illness can temporarily bring back old symptoms (a pseudorelapse), pacing activity and staying cool help many people. Ongoing care usually means neurology visits and periodic MRI scans, plus whatever blood tests or other checks the chosen medicine requires. MRI matters because new lesions can appear without new symptoms, which may signal that treatment needs to change. Not smoking, staying active and managing other health conditions also support long-term outcomes. Pregnancy is possible, and MS generally does not make it riskier. Relapses usually become less frequent during pregnancy, especially in the last trimester, and more likely in the months after delivery. Because many DMTs are stopped or carefully timed around conception, planning a pregnancy with the neurologist ahead of time is important. After an unplanned pregnancy, contact the neurologist promptly rather than stopping a medicine on your own.
Symptoms that start suddenly, such as weakness or numbness on one side of the body, trouble speaking or a sudden loss of vision, need emergency care (call 911) because they can be signs of a stroke. See a doctor about numbness, weakness or balance problems that develop more gradually, last more than a day or keep coming back. Blurred or lost vision in one eye, especially with pain when moving the eye, should be checked the same day. A neurologist can work out whether MS or another condition is responsible. If you have MS, contact your MS care team promptly about new symptoms, or a clear worsening of old ones, that last more than 24 hours without a fever or infection to explain them. This may be a relapse, and the team can decide whether it needs treatment. If old symptoms flare along with a fever, signs of infection such as burning when you urinate, or overheating, let the team know as well: the infection may need its own treatment, and the flare usually settles as it clears. Raise ongoing problems with mood, memory, bladder control or medicine side effects at your next visit, or sooner if they are troubling.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Relapsing-Remitting Multiple Sclerosis is like, what's helped you, or ask the community a question.